CATEGORIES

A Vaccine For Alzheimer's?

United Neuroscience’s small Phase II trial appears to have cleared a decades-old hurdle

An Investing Prophet Takes On Climate Change

Jeremy Grantham wants to devote $1 billion to help the world avoid calamity

The Bitter Angels Of Trump's Nature

Mick Mulvaney and Stephen Miller encourage the president’s disruptive instincts

World's Hottest Stock Market

The Jamaican stock market is so obscure, even emerging markets funds don’t invest there. And it’s booming

Can Shell Shed Its Dirty Past?

The oil giant wants to be a player in cleaner energy. But it has a Nigeria legacy to scrub

The True Cost Of Unreported Sexual Harassment

The culture that discouraged Christine Blasey Ford from alleging sexual assault punishes women throughout their careers

You Can't See Apple's Most Lucrative iPhone Feature

The new 512GB storage chip could make the company $134 more per phone than the 256GB option

Trump's Tariffs Drive Up The Cost Of Public Works

Duties are adding about $1.3 million to the price tag of steel on a Detroit river cleanup

Robert Mueller's Ride Isn't Over Yet

Robert Mueller’s Russia investigation may have more thrills in store

Harley Davidson- The Hog ​​​​​​​of Tomorrow

Harley’s future looks nothing like its past.

Can Snap Seize The Moment?

Nobody trusts Facebook. Twitter is a hot mess. Can Evan Spiegel keep Snapchat from disappearing?

China Cleans Up Its (Trash) Act

Stricter rules on imported recycled goods have mainland businesses buying U.S. plants to get their waste.

Electric Cars Threaten Japan's Industrial Heartland

Auto suppliers in Aichi are bracing for the eventual demise of the combustion engine.

How To Make A Perfume Smell Expensive

Small fragrance creators such as Maelstrom in Paris are influencing a $49 billion global industry.

A Voyage Down Modi's Ganges

The Indian prime minister wants a second fiveyear term. To win reelection he’ll have to convince the people along the country’s holiest river that their lives have improved

When A Drug Is Too Effective To Succeed

New antibiotics are needed to combat widespread resistance to older ones. But doctors tend to hold them in reserve—hurting sales

The Miracle Of Microsoft

Microsoft, that blue screen of irrelevance, is bigger than Apple (slightly), Amazon, and everybody else. How’d that happen?

Globalism Is Alive and Well

The quintessential postnational, transborder, free-trading CEO in the age of Trump.

John Maynard Trump

How the next White House could justify a debt-driven Keynesian stimulus

Ford Has Some Catching Up To Do

It’s tapped outsider Jim Hackett as CEO to prepare for the industry’s digital and driverless reboot

Smoke Was Pouring Out Of Fyre Media Weeks Before Its Disastrous Music Festival

The app maker behind the festival was in trouble well before partygoers arrived in the Bahamas

Lifestyles Of The Rich And Not-Quite Internet Famous

For just $25,000 a month, you, too, can have your own social media team.

Man of the (Very Rich) People

Wilbur Ross is the face of Donald Trump's experiment in government by-and possibly for-the plutocracy.

Making Ethical Fashion Chic

Everlane goes to China to pick a new bag factory.

The Solar Company Making a Profit on Poor Africans

M-Kopa plans to be a $1 billion company by selling solar panels to rural residents and providing them with credit.

How Dow Chemical Is Turning Sewage Into a Refreshing Drink

Dow chemical is turning sewage into a refreshing drink.

A New Type of Terror Emerges in America

Plots outside the command and control of extremist groups are difficult to detect

Why This Year’s Christmas Season Is So Angry

A well-functioning economy requires trust. But this election season is all about dread.

Serial: Audio Fit for Binge Consumption

The second season of the podcast Serial surprises and delights fans—and gets Hollywood interested. 

Toxic Burrito: Can Chipotle Get Over Food Poisoning?

Chipotle's crisis